Skip to main content

Ischemic Preconditioning and Lung Preservation

  • Chapter
  • First Online:
  • 1051 Accesses

Abstract

Postoperative lung complications, arising from lung injury, occur during conventional cardiac surgery and during transplantation of the lung; both these procedures involve cardiopulmonary bypass (CPB). Lung injury is associated with various pathophysiological events that occur during CPB or the long-term storage of lungs during preservation. These events include ischemiareperfusion (I/R)/hypoxia-reoxygenation, inflammation, and generation of reactive oxygen species (ROS). To counteract these adverse pathophysiological effects, there are a number of techniques currently in use to protect the lung during cardiac surgery and lung transplantation. These include the use of continuous inflation or ventilation, various protective or preservation solutions, together with the potential for exploiting the endogenous protective mechanism of preconditioning. This chapter briefly reviews the causes and mechanisms of lung injury and the techniques introduced to ameliorate this injury but focuses predominantly on the current evidence for preconditioning protection of the lung, including methods of initiating preconditioning in the lung (with emphasis on potentially clinically relevant triggers) to improve lung protection or preservation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med. 2003;167(4):490-511.

    Article  PubMed  Google Scholar 

  2. Troosters T, Gosselink R, Decramer M. Chronic obstructive pulmonary disease and chronic heart failure: two muscle diseases? J Cardiopulm Rehabil. 2004;24(3):137-145.

    Article  PubMed  Google Scholar 

  3. Pespeni M, Hodnett M, Pittet JF. In vivo stress preconditioning. Methods. 2005;35(2):158-164.

    Article  PubMed  CAS  Google Scholar 

  4. Carvalho EM, Gabriel EA, Salerno TA. Pulmonary protection during cardiac surgery: systematic literature review. Asian Cardiovasc Thorac Ann. 2008;16(6):503-507.

    PubMed  Google Scholar 

  5. Ng CS, Wan S, Yim AP, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest. 2002;121(4):1269-1277.

    Article  PubMed  Google Scholar 

  6. Ng CS, Wan S, Yim AP. Pulmonary ischaemia-reperfusion injury: role of apoptosis. Eur Respir J. 2005;25(2):356-363.

    Article  PubMed  CAS  Google Scholar 

  7. Ng CS, Wan S, Arifi AA, Yim AP. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today. 2006;36(3):205-214.

    Article  PubMed  CAS  Google Scholar 

  8. Balogun E, Featherstone RL, Chambers DJ. Lung injury during cardiopulmonary bypass: characteristics of deflation-induced injury and attenuation with theophylline. Interact Cardiovasc Thorac Surg. 2006;5(suppl 2):S198-S199.

    Google Scholar 

  9. Slutsky AS. Lung injury caused by mechanical ventilation. Chest. 1999;116(1 suppl):9S-15S.

    PubMed  CAS  Google Scholar 

  10. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA. Hyperoxia increases ventilator-induced lung injury via mitogen-activated protein kinases: a prospective, controlled animal experiment. Crit Care. 2007;11(1):R25.

    Article  PubMed  Google Scholar 

  11. de Perrot M, Keshavjee S. Lung preservation. Semin Thorac Cardiovasc Surg. 2004;16(4):300-308.

    Article  PubMed  Google Scholar 

  12. de Perrot M, Bonser RS, Dark J, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. J Heart Lung Transplant. 2005;24(10):1460-1467.

    Article  PubMed  Google Scholar 

  13. de Antonio DG, de Ugarte AV. Present state of nonheart-beating lung donation. Curr Opin Organ Transplant. 2008;13(6):659-663.

    Article  PubMed  Google Scholar 

  14. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol. 2008;294(4):L632-L641.

    Article  PubMed  CAS  Google Scholar 

  15. Featherstone RL, Kelly FJ, Shattock MJ, Hearse DJ, Chambers DJ. Hypothermic preservation of isolated rat lungs in modified bicarbonate buffer, EuroCollins solution or St Thomas’ Hospital cardioplegic solution. Eur J Cardiothorac Surg. 1998;14(5):508-515.

    Article  PubMed  CAS  Google Scholar 

  16. Featherstone RL, Kelly FJ, Chambers DJ. Theophylline improves functional recovery of isolated rat lungs after hypothermic preservation. Ann Thorac Surg. 1999;67(3):798-803.

    Article  PubMed  CAS  Google Scholar 

  17. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124-1136.

    Article  PubMed  CAS  Google Scholar 

  18. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 2003;83(4):1113-1151.

    PubMed  CAS  Google Scholar 

  19. Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev. 2007;12(3–4):181-188.

    Article  PubMed  CAS  Google Scholar 

  20. Downey JM, Krieg T, Cohen MV. Mapping preconditioning’s signaling pathways: an engineering approach. Ann N Y Acad Sci. 2008;1123:187-196.

    Article  PubMed  CAS  Google Scholar 

  21. Du ZY, Hicks M, Winlaw D, Spratt P, Macdonald P. Ischemic preconditioning enhances donor lung preservation in the rat. J Heart Lung Transplant. 1996;15(12):1258-1267.

    PubMed  CAS  Google Scholar 

  22. Li G, Chen S, Lu E, Hu T. Protective effects of ischemic preconditioning on lung ischemia reperfusion injury: an in-vivo rabbit study. Thorac Cardiovasc Surg. 1999;47(1):38-41.

    Article  PubMed  CAS  Google Scholar 

  23. Gasparri RI, Jannis NC, Flameng WJ, Lerut TE, Van Raemdonck DE. Ischemic preconditioning enhances donor lung preservation in the rabbit. Eur J Cardiothorac Surg. 1999;16(6):639-646.

    Article  PubMed  CAS  Google Scholar 

  24. Soncul H, Oz E, Kalaycioglu S. Role of ischemic preconditioning on ischemia-reperfusion injury of the lung. Chest. 1999;115(6):1672-1677.

    Article  PubMed  CAS  Google Scholar 

  25. Featherstone RL, Chambers DJ, Kelly FJ. Ischemic preconditioning enhances recovery of isolated rat lungs after hypothermic preservation. Ann Thorac Surg. 2000;69(1):237-242.

    Article  PubMed  CAS  Google Scholar 

  26. Ucar G, Topaloglu E, Kandilci HB, Gumusel B. Effect of ischemic preconditioning on reactive oxygen species-mediated ischemia–reperfusion injury in the isolated perfused rat lung. Clin Biochem. 2005;38(7):681-684.

    Article  PubMed  CAS  Google Scholar 

  27. Ucar G, Topaloglu E, Burak Kandilci H, Gumusel B. Elevated semicarbazide-sensitive amine oxidase (SSAO) activity in lung with ischemia-reperfusion injury: protective effect of ischemic preconditioning plus SSAO inhibition. Life Sci 2005;78(4):421–427

    Google Scholar 

  28. Friedrich I, Spillner J, Lu EX, et al. Ischemic pre-conditioning of 5 minutes but not of 10 improves lung function after warm ischemia in a canine model. J Heart Lung Transplant. 2001;20(9):985-995.

    Article  PubMed  CAS  Google Scholar 

  29. Ahmad S, Ahmad A, Gerasimovskaya E, Stenmark KR, Allen CB, White CW. Hypoxia protects human lung microvascular endothelial and epithelial-like cells against oxygen toxicity: role of phosphatidylinositol 3-kinase. Am J Respir Cell Mol Biol. 2003;28(2):179-187.

    Article  PubMed  CAS  Google Scholar 

  30. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res. 2008;77(2):344-352.

    Article  PubMed  CAS  Google Scholar 

  31. Wang W, Jia L, Wang T, Sun W, Wu S, Wang X. Endogenous calcitonin gene-related peptide protects human alveolar epithelial cells through protein kinase C epsilon and heat shock protein. J Biol Chem. 2005;280(21):20325-20330.

    Article  PubMed  CAS  Google Scholar 

  32. Zhang SX, Miller JJ, Gozal D, Wang Y. Whole-body hypoxic preconditioning protects mice against acute hypoxia by improving lung function. J Appl Physiol. 2004;96(1):392-397.

    Article  PubMed  Google Scholar 

  33. Zhang SX, Miller JJ, Stolz DB, et al. Type I epithelial cells are the main target of whole-body hypoxic preconditioning in the lung. Am J Respir Cell Mol Biol. 2009;40(3):332-339.

    Article  PubMed  CAS  Google Scholar 

  34. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol. 2000;62:79-109.

    Article  PubMed  CAS  Google Scholar 

  35. Neely CF, Keith IM. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung. Am J Physiol. 1995;268(6 pt 1):L1036-L1046.

    PubMed  CAS  Google Scholar 

  36. Featherstone RL, Chambers DJ. Long-term hypothermic lung preservation: does adenosine A1 receptor antagonism have a role in ischemic preconditioning protection? Interact Cardiovasc Thorac Surg. 2004;3(1):182-187.

    Article  PubMed  Google Scholar 

  37. Waldow T, Alexiou K, Witt W, et al. Attenuation of reperfusion-induced systemic inflammation by preconditioning with nitric oxide in an in situ porcine model of normothermic lung ischemia. Chest. 2004;125(6):2253-2259.

    Article  PubMed  CAS  Google Scholar 

  38. Waldow T, Alexiou K, Witt W, et al. Protection of lung tissue against ischemia/reperfusion injury by preconditioning with inhaled nitric oxide in an in situ pig model of normothermic pulmonary ischemia. Nitric Oxide. 2004;10(4):195-201.

    Article  PubMed  CAS  Google Scholar 

  39. Waldow T, Witt W, Buzin A, Ulmer A, Matschke K. Prevention of ischemia/reperfusion-induced accumulation of matrix metalloproteinases in rat lung by preconditioning with nitric oxide. J Surg Res 2009;152:198–208

    Google Scholar 

  40. Waldow T, Witt W, Ulmer A, Janke A, Alexiou K, Matschke K. Preconditioning by inhaled nitric oxide prevents hyperoxic and ischemia/reperfusion injury in rat lungs. Pulm Pharmacol Ther. 2008;21(2):418-429.

    Article  PubMed  CAS  Google Scholar 

  41. Turan NN, Demiryurek AT. Preconditioning effects of peroxynitrite in the rat lung. Pharmacol Res. 2006;54(5):380-388.

    Article  PubMed  CAS  Google Scholar 

  42. Pizanis N, Milekhin V, Tsagakis K, Aleksic I, Kamler M, Jakob H. PDE-5 inhibitor donor intravenous preconditioning is superior to supplementation in standard preservation solution in experimental lung transplantation. Eur J Cardiothorac Surg. 2007;32(1):42-47.

    Article  PubMed  Google Scholar 

  43. Fukuse T, Hirata T, Omasa M, Wada H. Effect of adenosine triphosphate-sensitive potassium channel openers on lung preservation. Am J Respir Crit Care Med. 2002;165(11):1511-1515.

    Article  PubMed  Google Scholar 

  44. Tang DG, Pavot DR, Mouria MM, Holwitt DM, Cohen NM. Warm ischemia lung protection with pinacidil: an ATP regulated potassium channel opener. Ann Thorac Surg 2003;76(2):385–389; discussion 389–390

    Google Scholar 

  45. Gohrbandt B, Fischer S, Warnecke G, et al. Glycine intravenous donor preconditioning is superior to glycine supplementation to low-potassium dextran flush preservation and improves graft function in a large animal lung transplantation model after 24 hours of cold ischemia. J Thorac Cardiovasc Surg. 2006;131(3):724-729.

    Article  PubMed  CAS  Google Scholar 

  46. Weinbroum AA, Kluger Y, Ben Abraham R, Shapira I, Karchevski E, Rudick V. Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion injury after liver no flow-reflow: a dose-response study. Transplantation 2001;71(2):300–306

    Google Scholar 

  47. Javadpour M, Kelly CJ, Chen G, Stokes K, Leahy A, Bouchier-Hayes DJ. Thermotolerance induces heat shock protein 72 expression and protects against ischaemia-reperfusion-induced lung injury. Br J Surg. 1998;85(7):943-946.

    Article  PubMed  CAS  Google Scholar 

  48. McCormick PH, Chen G, Tlerney S, Kelly CJ, Bouchier-Hayes DJ. Clinically relevant thermal preconditioning attenuates ischemia-reperfusion injury. J Surg Res. 2003;109(1):24-30.

    Article  PubMed  CAS  Google Scholar 

  49. Thomas S, Pulimood A, Balasubramanian KA. Heat preconditioning prevents oxidative stress-induced damage in the intestine and lung following surgical manipulation. Br J Surg. 2003;90(4):473-481.

    Article  PubMed  CAS  Google Scholar 

  50. Luh SP, Kuo PH, Kuo TF, et al. Effects of thermal preconditioning on the ischemia-reperfusion-induced acute lung injury in minipigs. Shock. 2007;28(5):615-622.

    PubMed  CAS  Google Scholar 

  51. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic “preconditioning” protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87(3):893-899.

    Article  PubMed  CAS  Google Scholar 

  52. Ambros JT, Herrero-Fresneda I, Borau OG, Boira JM. Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int. 2007;20(3):219-229.

    Article  PubMed  CAS  Google Scholar 

  53. Ito K, Ozasa H, Kojima N, et al. Pharmacological preconditioning protects lung injury induced by intestinal ischemia/reperfusion in rat. Shock. 2003;19(5):462-468.

    Article  PubMed  CAS  Google Scholar 

  54. Kalb R, Schober P, Schwarte LA, Weimann J, Loer SA. Preconditioning, but not postconditioning, with Sevoflurane reduces pulmonary neutrophil accumulation after lower body ischaemia/reperfusion injury in rats. Eur J Anaesthesiol. 2008;25(6):454-459.

    Article  PubMed  CAS  Google Scholar 

  55. Xia Z, Herijgers P, Nishida T, Ozaki S, Wouters P, Flameng W. Remote preconditioning lessens the deterioration of pulmonary function after repeated coronary artery occlusion and reperfusion in sheep. Can J Anaesth. 2003;50(5):481-488.

    Article  PubMed  Google Scholar 

  56. Waldow T, Alexiou K, Witt W, et al. Protection against acute porcine lung ischemia/reperfusion injury by systemic preconditioning via hind limb ischemia. Transpl Int. 2005;18(2):198-205.

    Article  PubMed  CAS  Google Scholar 

  57. Li G, Chen S, Lu E, Luo W. Cardiac ischemic preconditioning improves lung preservation in valve replacement operations. Ann Thorac Surg. 2001;71(2):631-635.

    Article  PubMed  CAS  Google Scholar 

  58. Cheung MM, Kharbanda RK, Konstantinov IE, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol. 2006;47(11):2277-2282.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David J. Chambers .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer London

About this chapter

Cite this chapter

Chambers, D.J., Fallouh, H.B., Kassem, N.A. (2010). Ischemic Preconditioning and Lung Preservation. In: Gabriel, E., Salerno, T. (eds) Principles of Pulmonary Protection in Heart Surgery. Springer, London. https://doi.org/10.1007/978-1-84996-308-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-308-4_23

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-307-7

  • Online ISBN: 978-1-84996-308-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics